Hostname: page-component-7c8c6479df-ws8qp Total loading time: 0 Render date: 2024-03-28T09:34:18.036Z Has data issue: false hasContentIssue false

Impact of a total smoking ban in a high secure hospital

Published online by Cambridge University Press:  02 January 2018

Irene Cormac*
Affiliation:
Rampton Hospital, Retford
Sandra Creasey
Affiliation:
Rampton Hospital, Retford
Ann McNeill
Affiliation:
City Hospital, Nottingham
Michael Ferriter
Affiliation:
Rampton Hospital, Retford
Bernard Huckstep
Affiliation:
Rampton Hospital, Retford
Karen D'Silva
Affiliation:
Rampton Hospital, Retford
*
Rights & Permissions [Opens in a new window]

Abstract

Aims and method

To assess the impact of a total smoking ban in a high secure psychiatric hospital. Staff and patients were surveyed before and after implementation. Data were collected on untoward incidents, seclusions, nicotine replacement therapy and changes in psychotropic medication.

Results

Of the 298 patients in the hospital for the evaluation period, 72.8% were smokers before the ban. There were no significant differences in rates of seclusion before and after the ban and only one significant comparison (P =0.01) showed an increase in untoward incidents for smokers. There were no significant increases in the use of psychotropic medication after the ban.

Clinical implications

With adequate preparation, it is possible to implement a total smoking ban in a high secure psychiatric setting without serious negative consequences.

Type
Original Papers
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 2010

Smoking causes almost 90% of deaths from lung cancer, about 80% of deaths from bronchitis and emphysema, and approximately 17% of deaths from heart disease. It increases the risk of developing cancer of the mouth, lip, throat, bladder, kidney, stomach, liver and cervix. 1

Implementing smoke-free policies in mental health settings presents a challenge. Reference Campion, Lawn, Brownlie, Hunter, Gynther and Pols2 Smoking is more prevalent among people with mental health problems than the general population, Reference Meltzer, Gill, Petticrew and Hinds3 particularly among those with severe mental illness. Reference Coulthard, Farrell, Singleton and Meltzer4 Smokers with mental health problems are also more likely to smoke heavily and show signs of more severe nicotine dependence. Reference Williams, Ziedonis, Abanyie, Steinberg, Foulds and Benowitz5

Barriers to reduction of smoking in in-patient psychiatric settings include anxiety that smoking cessation could lead to deterioration in mental health and behaviour. There are high rates of smoking in mental healthcare professionals, Reference Rowe and Clark6 some of whom have negative attitudes towards smoke-free policies, with a significant minority believing that there was some therapeutic benefit from patients being allowed to smoke. Reference Dickens, Stubbs and Haw7

The Health Act 2006 required that all indoor and substantially enclosed outdoor workplaces and public places in England and Wales became smoke-free by 1 July 2007. Residential mental health settings were given a temporary exemption for 1 year only.

Nottinghamshire Healthcare National Health Service (NHS) Trust introduced a total smoking ban for all mental health units within the Trust on 31 March 2007. This included Rampton Hospital, a high secure, long-stay psychiatric hospital for patients with complex mental health disorders who are a grave and immediate danger to the public or themselves (the majority have committed serious offences). Rampton Hospital was the first high secure hospital in the UK to become smoke-free.

A previous survey showed that approximately 70% of patients in Rampton Hospital were smokers and most were heavy smokers. Reference Cormac, Ferriter, Benning and Saul8 Three months before the hospital became smoke-free, patients were informed about the new smoke-free policy and were offered help to stop smoking, including nicotine replacement therapy. Extensive preparations were implemented before the ban including staff training and information for both staff and patients. Individual support was provided for patients by nursing staff. It was made clear that the ban would be universal and apply to staff in the workplace as well as patients. These were among the salient factors that were later to be identified by Campion et al 9 as crucial for the successful implementation of a smoke-free policy.

When the smoke-free policy was introduced, tobacco and ignition sources became prohibited for patients, staff and visitors, and this was rigorously enforced in the hospital. On the weekend of the policy introduction, all wards were fully staffed and additional activities were provided as a distraction.

We report a retrospective evaluation of the impact of the smoking ban. The evaluation met the criteria for a service evaluation as defined by the National Patient Safety Agency Reference Cormac, Ferriter, Benning and Saul8 as it was designed and conducted solely to define or judge current care. It involved analysis of existing data and the use of simple questionnaires. The aim was to evaluate the impact of a total smoking ban in buildings and grounds in a high secure psychiatric hospital.

Method

The total ban in Rampton Hospital was implemented from midnight on 31 March 2007. We collected data before and after the ban on:

  1. survey of staff and patients

  2. untoward incidents and seclusions

  3. changes in psychotropic medication

  4. nicotine replacement therapy.

Staff and patient survey

A postal survey was undertaken of all staff and patients on their views on the ban both before (February 2007) and after implementation (July 2007), using a questionnaire specially developed for the purpose at Rampton Hospital.

Untoward incidents and seclusions

Data were obtained from the hospital risk department on untoward incidents including self-harm (threats or actual), verbal abuse and verbal aggression or threats, physical aggression (attempted or actual) and damage to property. In addition, we obtained data on untoward incidents of sufficient severity to require the patient to be placed in seclusion. Seclusion of a patient is defined in the Department of Health Code of Practice as ‘the supervised confinement of a patient in a room, which may be locked. Its sole aim is to contain severely disturbed behaviour which is likely to cause harm to others’ (p. 122). 10

We compared the number of seclusions in the month before the ban (March 2007) with the number of seclusions in the first month of the ban (April 2007) for those who had been smokers and for non-smokers. We carried out a similar comparison of seclusions for the months of December 2006 before the ban and July 2007 after the ban. The incidents that led to seclusions were categorised as threatening behaviour, attacks on staff and attacks on fellow patients. A similar strategy was used to analyse the data on all incidents.

Changes in psychotropic medication

Changes in psychotropic medication usage were obtained by scrutinising medication charts and from the hospital pharmacy database. Data were collected on regular and as required (PRN) antipsychotic and benzodiazepine medications for the months of December 2006 and March 2007 as baseline. Post-implementation data were obtained for April and July 2007.

The average daily dose of each medication was expressed as a percentage of the maximum British National Formulary (BNF) dose. For each patient, the daily percentages of the maximum BNF dose for each type of medication for the month were added together and then divided by the number of days in the month. If there were two or more medications in the same category, the data for these were summed.

We compared smokers' and non-smokers' use of four classes of psychotropic medication: regular antipsychotics, regular benzodiazepines, PRN antipsychotics, PRN benzodiazepines, comparing March with April and December with July using the t-test.

Nicotine replacement therapy

The number of patients receiving nicotine replacement therapy between December 2006 and July 2007 were recorded in the pharmacy database and these data were used in our evaluation.

Results

There were 340 resident patients in the hospital during the 8-month evaluation period. Of these, 42 patients were transferred elsewhere or were admitted to the hospital during this period. A total of 298 patients were resident in the hospital for the whole 8-month evaluation period, 217 of whom were smokers before the ban (72.8%). Only seven patients quit smoking in anticipation of the implementation of the smoke-free policy. Patients either made unsuccessful quit attempts or made no quit attempts before the policy was introduced.

Response rate

The pre-ban questionnaire was sent to 340 patients who were resident in the hospital in February 2007. Of these, 175 patients replied (51% response rate); 89% of the respondents were male and 70% reported being smokers. In June 2007, the second questionnaire was sent to the 328 patients resident at the time, of whom 115 replied (35% response rate); 85% were male and 87% reported being smokers before the ban.

The pre-ban questionnaire was sent to 1862 members of staff and 1038 responded (55.7% response rate); 46% of the respondents were male and 23% reported being smokers; 61% of the respondents were nurses. A total of 1946 questionnaires were sent to staff after the ban and 670 members of staff responded (34% response rate); 38% of the respondents were male, 22% reported being smokers and 54% were nurses.

Views of the ban among staff and patients

Before the ban, 40/175 patients (22.9%) and 528/1038 staff (50.9%) were in favour of the ban. After the implementation of the ban, the percentage of patients in favour of the ban had increased to 29/115 (25.2%) and the percentage of staff in favour of the ban had increased to 404/670 (60.3%).

Before the ban, 93/175 of patients (53.1%) believed their mental health would be adversely affected by the ban and 47/175 thought their physical health would be adversely affected (26.9%). However, after the ban, 45/115 of patients felt their mental health (39.1%) and 29/115 thought their physical health (25.2%) had been adversely affected.

Before the ban, 573/1038 of all staff (55.2%) and 409/538 of nursing staff (76%) were concerned that patients would be more aggressive if they could not smoke. However, after the ban, only 100/670 of all staff (14.9%) and 69/286 of nurses (24.1%) felt the smoking ban had made patients more aggressive.

Before the ban, 491/1038 of all staff (47.3%) and 359/538 of nurses (66.7%) thought patients were more likely to self-harm if they could not smoke. After the ban, only 55/670 of all staff (8.2%) and 36/286 of nurses (12.6%) believed that patients had self-harmed as a result of the ban. Before the ban, 477/1038 of all staff (46%) and 362/538 of nurses (67.3%) thought patients would need more medication because they could not smoke, but after the ban only 85/670 of all staff (12.7%) and 66/286 of nurses (23.1%) thought that patients had needed more medication because of the smoking ban.

Untoward incidents

Table 1 shows the number of incidents for the four time periods, for smokers, non-smokers and all patients. Table 2 shows the number of seclusions as a result of severe untoward incidents.

Table 1 Violent incidents in pre-ban smokers and non-smokers before and after the ban

December 2006 March 2007 April 2007 July 2007
Pre-ban smokers
   Self-harm 48 61 61 60
   Verbal abuse 84 95 85 99
   Physical aggression 25 22 30 34
   Damage to property 1 2 2 5
   Total 158 180 178 198
Pre-ban non-smokers
   Self-harm 27 21 20 26
   Verbal abuse 46 32 32 33
   Physical aggression 38 56 58 22
   Damage to property 1 1 2 2
   Total 112 110 112 83
All patients
   Self-harm 75 82 81 86
   Verbal abuse 130 127 117 132
   Physical aggression 63 78 88 56
   Damage to property 2 3 4 7
   Total 270 290 290 281

Table 2 Episodes of seclusion of pre-ban smokers and non-smokers before and after the ban

December 2006 March 2007 April 2007 July 2007
Pre-ban smokers
   Threatening behaviour 20 17 26 40
   Attacking staff 4 6 7 8
   Attacking fellow patient 2 4 5 6
   Total 26 27 38 54
Pre-ban non-smokers
   Threatening behaviour 9 23 19 6
   Attacking staff 3 5 6 8
   Attacking fellow patient 0 1 1 1
   Total 12 29 26 15
All patients
   Threatening behaviour 29 40 45 40
   Attacking staff 7 11 13 16
   Attacking fellow patient 2 5 6 7
   Total 38 56 64 63

Analyses were carried out using χ2-test of paired results, comparing the months of March and April 2007, December 2006 and July 2007, for both pre-ban smokers and non-smokers. Only one result was significant - the comparison of number of incidents for December and July. This showed significantly more incidents for pre-ban smokers in July than in December (P = 0.01, d.f. = 1). There were no significant results for comparisons of numbers of seclusions between pre-ban smokers or non-smokers for either time period comparison.

The hospital security department reported finding contraband tobacco and ignition sources on seven occasions after the ban. However, a full search of all patient areas was not carried out at the point of introduction of the ban and the majority of patients were simply asked to voluntarily surrender their smoking materials.

An analysis of the fire alarm record showed no incidents attributable to illicit smoking between December 2006 and July 2007 inclusive. There were no incidents of major indiscipline such as riots, hostage-taking or rooftop protests in the 4 months following the ban. Three patients sought to challenge the legality of the ban in the courts but this challenge has been rejected.

Changes in psychotropic medication

A comparison was made of pre-ban smokers' and non-smokers' use of four classes of psychotropic medication: regular antipsychotic medication, regular benzodiazepines, PRN antipsychotic medication, and PRN benzodiazepines. We compared March with April and December with July, using the t-test. Table 3 shows the results of these analyses in terms of mean doses for smokers and Table 4 shows the results for non-smokers. As described earlier, the unit of calculation is the dose of medication expressed as a percentage of the maximum BNF limit. The only statistically significant result (P=0.025) was a decline in mean dose of regular antipsychotic medication in smokers from March to April.

Table 3 Pre-ban smokers: comparison of mean dose of medication in the two study periods

Patients on medication n Mean (s.d.) s.e. 95% CI t d.f. P a
Regular antipsychotics
   March 166 64.06 (39.38) 3.06 0.37 to 5.42 2.27 165 0.025
   April 166 61.16 (37.37) 2.90
Regular benzodiazepines
   March 8 66.79 (80.37) 28.41 −12.57 to 16.08 0.29 7 0.78
   April 8 65.03 (89.62) 31.68
PRN antipsychotics
   March 27 2.76 (2.70) 0.52 −0.68 to 0.98 0.37 26 0.71
   April 27 2.61 (2.16) 0.41
PRN benzodiazepines
   March 21 8.55 (7.84) 1.71 −10.34 to 1.28 −1.63 20 0.12
   April 21 13.08 (16.77) 3.66
Regular antipsychotics
   December 158 64.96 (38.99) 3.10 −0.8 to 7.86 1.93 157 0.055
   July 158 61.07 (36.86) 2.93
Regular benzodiazepines
   December 8 51.38 (46.65) 16.49 −51.73 to 18.90 −1.10 7 0.31
   July 8 67.80 (84.94) 30.03
PRN antipsychotics
   December 14 1.83 (1.26) 0.33 −1.74 to 0.81 −0.79 13 0.44
   July 14 2.29 (2.28) 0.61
PRN benzodiazepines
   December 9 10.78 (7.43) 2.48 −14.70 to 8.64 −0.60 8 0.57
   July 9 13.81 (14.41) 4.80

Table 4 Pre-ban non-smokers: comparison of mean dose of medication in the two study periods

Patients on medication n Mean (s.d.) s.e. 95% CI t d.f. P a
Regular antipsychotics
   March 56 62.90 (40.21) 5.37 −0.81 to 0.72 −0.13 55 0.90
   April 56 62.95 (40.37) 5.39
Regular benzodiazepines
   March 3 52.04 (41.87) 24.17 −3.32 to 5.34 1.00 2 0.42
   April 3 51.03 (42.94) 24.79
PRN antipsychotics
   March 4 1.18 (1.01) 0.50 −7.66 to 0.68 −2.66 3 0.08
   April 4 4.67 (2.78) 1.39
PRN benzodiazepines
   March 6 9.32 (8.08) 3.30 −7.57 to 0.56 −2.22 5 0.08
   April 6 12.82 (9.86) 4.02
Regular antipsychotics
   December 53 63.32 (38.57) 5.30 −5.07 to 1.16 −1.26 52 0.21
   July 53 65.28 (41.01) 5.63
Regular benzodiazepines
   December 3 56.06 (38.06) 21.97 −26.99 to 43.34 1.00 2 0.42
   July 3 47.88 (46.68) 26.89
PRN antipsychotics
   December 3 3.40 (4.07) 2.35 −10.62 to 16.85 0.71 2 0.55
   July 3 1.29 (1.69) 0.98
PRN benzodiazepines
   December 4 11.49 (9.73) 4.86 −9.69 to 23.40 1.32 3 0.28
   July 4 4.64 (1.37) 0.69

Nicotine replacement therapy

A total of 149 patients commenced nicotine replacement therapy between December 2006 and March 2007. An additional 18 patients commenced the therapy after the ban.

Discussion

The implementation of a smoke-free policy in Rampton Hospital provided a rare opportunity to evaluate the impact of a total smoking ban in a highly controlled environment. Unlike other health facilities in the UK, it was not possible for patients to go outside the buildings or grounds to smoke, because of security restrictions. As a high secure hospital, effective search policies and procedures were already present to prevent contraband items entering the hospital and this was extended to tobacco and smoking-related materials.

However, owing to the opportunistic nature of this evaluation, there were limits to the data that were available for evaluation; moreover, data were available only for four time periods. The statistically significant result for the comparison of December and July incidents may be an artefact of a potentially seasonal drop in incidents in the period before Christmas.

We are not in a position to say whether any patients were transferred or discharged during the study period for reasons connected with the smoking ban but we consider the number to be few, if any. Wishing to smoke tobacco or deterioration in behaviour would not normally be considered a sufficient reason for leaving the hospital.

Staff concerns about patients' aggression, self-harm and increased need for medication decreased after the ban, but were consistently higher among nurses. A major problem with these data is that because the questionnaires were anonymous it was not possible to link the pre-ban responses to the post-ban responses for either patients or staff. It is possible that those staff members and patients who responded to the pre-ban questionnaire represented biased samples (i.e. of those who were more hostile to the ban), whereas those who responded to the post-ban questionnaire were more pro-ban. This potential source of bias could account for any changes in favour of the ban.

Despite the fears of staff and patients, the transition from a smoking environment to a non-smoking environment went smoothly. Our results do not show a marked increase in use of psychotropic medication, self-harm or behavioural disturbance as a result of the smoking ban. This evaluation replicates the findings of Hempel et al, Reference Hempel, Kownacki, Malin, Ozone and Cormack11 who reported a similar uneventful transition to a non-smoking environment in a maximum security hospital in the USA. However, in another paper Reference Cormac, Brown, Creasey, Ferriter and Huckstep12 we describe one of the few potential problems of abrupt smoking cessation, which was an increase in clozapine plasma levels for individuals who quit smoking.

Cormac & McNally Reference Cormac and McNally13 have described the strategy used to implement the total ban on smoking, which was applied at Rampton Hospital. This strategy could be applied in other psychiatric settings. What is now required is a long-term evaluation of the health benefits of smoke-free environments to patients in Rampton Hospital and other long-stay NHS facilities.

This evaluation supports taking a robust approach to tackling smoking in psychiatric settings and should give confidence to those considering the implementation of a total rather than partial smoking ban in their psychiatric service.

Acknowledgements

We thank John White, Chief Pharmacist, Rampton Hospital, for providing the data on medications, and Dr Victoria Owen, Medical Statistician, National Institute for Health Research (NIHR) Research Design Service for the East Midlands (NDL), for advice on statistical analysis.

Footnotes

Declaration of interest

None.

References

1 Action on Smoking and Health. Facts at a Glance: Smoking and Disease. ASH, 2007 (http://www.ash.org.uk/files/documents/ASH_94.pdf).Google Scholar
2 Campion, J, Lawn, S, Brownlie, A, Hunter, E, Gynther, B, Pols, R. Implementing smoke-free policies in mental health inpatient units: learning from unsuccessful experience. Australas Psychiatry 2008; 16: 92–7.Google Scholar
3 Meltzer, H, Gill, B, Petticrew, M, Hinds, K. OPCS Surveys of Psychiatric Morbidity in Great Britain, Report 3: Economic Activity and Social Functioning of Adults with Psychiatric Disorders. HMSO, 1995.Google Scholar
4 Coulthard, M, Farrell, M, Singleton, N, Meltzer, H. Tobacco, Alcohol and Drug Use and Mental Health. TSO (The Stationery Office), 2002.Google Scholar
5 Williams, JM, Ziedonis, DM, Abanyie, F, Steinberg, ML, Foulds, J, Benowitz, NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorders is not a metabolic effect. Schizophr Res 2005; 79: 323–35.Google Scholar
6 Rowe, K, Clark, JM. The incidence of smoking amongst nurses: a review of the literature. J Adv Nursing 2000; 31: 1046–53.CrossRefGoogle ScholarPubMed
7 Dickens, GL, Stubbs, JH, Haw, CM. Smoking and mental health nurses: a survey of clinical staff in a psychiatric hospital. J Psychiatr Ment Health Nurs 2004; 11: 445–51.Google Scholar
8 Cormac, I, Ferriter, M, Benning, R, Saul, C. Physical health and health risk factors in a population of long-stay psychiatric patients. Psychiatr Bull 2005; 29: 1820.Google Scholar
10 Department of Health. Code of Practice: Mental Health Act 1983 – Revised 2008. TSO (The Stationery Office), 2008.Google Scholar
11 Hempel, AG, Kownacki, R, Malin, DH, Ozone, SJ, Cormack, TS, Sandoval 3rd BG, et al. Effect of a total smoking ban in a maximum security psychiatric hospital. Behav Sci Law 2002; 20: 507–22.Google Scholar
12 Cormac, I, Brown, A, Creasey, S, Ferriter, M, Huckstep, B. A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine. Acta Psychiatr Scand 2010; 121: 393–7.CrossRefGoogle ScholarPubMed
13 Cormac, I, McNally, L. How to implement a smoke-free policy. Adv Psychiatr Treat 2008; 14: 198207.CrossRefGoogle Scholar
Figure 0

Table 1 Violent incidents in pre-ban smokers and non-smokers before and after the ban

Figure 1

Table 2 Episodes of seclusion of pre-ban smokers and non-smokers before and after the ban

Figure 2

Table 3 Pre-ban smokers: comparison of mean dose of medication in the two study periods

Figure 3

Table 4 Pre-ban non-smokers: comparison of mean dose of medication in the two study periods

Submit a response

eLetters

No eLetters have been published for this article.